All issues
Volume 31, Issue 3Supplement2
Displaying 1-19 of 19 articles from this issue
- |<
- <
- 1
- >
- >|
-
[in Japanese]1985 Volume 31 Issue 3Supplement2 Pages 633-634
Published: July 10, 1985
Released on J-STAGE: May 10, 2013
JOURNAL FREE ACCESSDownload PDF (259K) -
[in Japanese], [in Japanese], [in Japanese], [in Japanese]1985 Volume 31 Issue 3Supplement2 Pages 635-638
Published: July 10, 1985
Released on J-STAGE: May 10, 2013
JOURNAL FREE ACCESSDownload PDF (473K) -
[in Japanese]1985 Volume 31 Issue 3Supplement2 Pages 639-640
Published: July 10, 1985
Released on J-STAGE: May 10, 2013
JOURNAL FREE ACCESSDownload PDF (269K) -
[in Japanese], [in Japanese], [in Japanese], [in Japanese], [in Japane ...1985 Volume 31 Issue 3Supplement2 Pages 641-643
Published: July 10, 1985
Released on J-STAGE: May 10, 2013
JOURNAL FREE ACCESSDownload PDF (3224K) -
Akinori KIDA, Shigeru KAWAMURA, Toru FURUSAKA, Yutaka YOKODE, Hitoshi ...1985 Volume 31 Issue 3Supplement2 Pages 644-648
Published: July 10, 1985
Released on J-STAGE: May 10, 2013
JOURNAL FREE ACCESSMaxillary sinus cancer usually is treated by radiotherapy, chemotherapy and surgery. In addition to this traditional combination therapy, we used a bleomycin-containing silicone foam placed in the space of operative wound for 7 days following surgery in 27 untreated maxillary sinus cancer patients for the purpose of coping with tumor cells remaining postoperatively. Silicone has a property of slowly releasing a drug it contains. The silicone preparation used was Q7-4290 Prosthetic Foam (Dow Corning). Tumor tissue levels of anticancer drug yielded by the use of the silicone foam were adequately high, being 1.5μg/g at Day 1, 4.6μg/g at Day 4 and 2.5μg/g at Day 7. During the follow-up observation period, which ranged from 7 to 36 months, there were 6 cases of a local recurrence of malignancy. Recurrence occurred within 6 months in 5 (19%) of 27 cases and between 6 and 12 months in 1 (6%) of 17 cases. Of 10 cases who have been followed up for more than 2 years, none had a recurrence or re-recurrence later than one year after receiving the therapeutic procedure.View full abstractDownload PDF (670K) -
[in Japanese]1985 Volume 31 Issue 3Supplement2 Pages 649-651
Published: July 10, 1985
Released on J-STAGE: May 10, 2013
JOURNAL FREE ACCESSDownload PDF (1839K) -
[in Japanese]1985 Volume 31 Issue 3Supplement2 Pages 652-654
Published: July 10, 1985
Released on J-STAGE: May 10, 2013
JOURNAL FREE ACCESSDownload PDF (370K) -
[in Japanese], [in Japanese]1985 Volume 31 Issue 3Supplement2 Pages 655-657
Published: July 10, 1985
Released on J-STAGE: May 10, 2013
JOURNAL FREE ACCESSDownload PDF (381K) -
[in Japanese], [in Japanese], [in Japanese], [in Japanese], [in Japane ...1985 Volume 31 Issue 3Supplement2 Pages 658-662
Published: July 10, 1985
Released on J-STAGE: May 10, 2013
JOURNAL FREE ACCESSDownload PDF (2591K) -
[in Japanese]1985 Volume 31 Issue 3Supplement2 Pages 663-665
Published: July 10, 1985
Released on J-STAGE: May 10, 2013
JOURNAL FREE ACCESSDownload PDF (2430K) -
[in Japanese]1985 Volume 31 Issue 3Supplement2 Pages 666-669
Published: July 10, 1985
Released on J-STAGE: May 10, 2013
JOURNAL FREE ACCESSDownload PDF (479K) -
[in Japanese]1985 Volume 31 Issue 3Supplement2 Pages 670-673
Published: July 10, 1985
Released on J-STAGE: May 10, 2013
JOURNAL FREE ACCESSDownload PDF (451K) -
[in Japanese]1985 Volume 31 Issue 3Supplement2 Pages 674-679
Published: July 10, 1985
Released on J-STAGE: May 10, 2013
JOURNAL FREE ACCESSDownload PDF (743K) -
Katsutake HAYASAKI, Toshio KANEKO, Haruhiko SUZUKI, Akiko SHIMADA1985 Volume 31 Issue 3Supplement2 Pages 680-684
Published: July 10, 1985
Released on J-STAGE: May 10, 2013
JOURNAL FREE ACCESSEight patients with far-advanced head and neck cancer were treated with combined cisplatin and peplomycin chemotherapy. 75mgs of cisplatin was administered intravenously on the 1st day, followed by 10mgs of peplomycin on the 2nd to 7th day. Complete response was obtained in 3 cases, and a partial response in 4 cases, with an overall response rate of 87.5%. Side effects such as nausea and vomitting (62.5%), anorexia (62.5%), depilation (50%), facial edema (12.5%) and leucopenia (12.5%) appeared in evey case. However, all of these were slight in grade and temporary. In conclusion, combined therapy using cisplatin and peplomycin was considered to be of use in far-advanced cases of head and neck cancer. In addition, of of this therapy was also suggested for the combined use with radiation and for the prophylactic use following major surgery.View full abstractDownload PDF (622K) -
[in Japanese], [in Japanese]1985 Volume 31 Issue 3Supplement2 Pages 685-687
Published: July 10, 1985
Released on J-STAGE: May 10, 2013
JOURNAL FREE ACCESSDownload PDF (312K) -
[in Japanese], [in Japanese]1985 Volume 31 Issue 3Supplement2 Pages 688-694
Published: July 10, 1985
Released on J-STAGE: May 10, 2013
JOURNAL FREE ACCESSDownload PDF (6864K) -
[in Japanese], [in Japanese], [in Japanese], [in Japanese]1985 Volume 31 Issue 3Supplement2 Pages 695-702
Published: July 10, 1985
Released on J-STAGE: May 10, 2013
JOURNAL FREE ACCESSDownload PDF (996K) -
[in Japanese], [in Japanese], [in Japanese], [in Japanese]1985 Volume 31 Issue 3Supplement2 Pages 703-706
Published: July 10, 1985
Released on J-STAGE: May 10, 2013
JOURNAL FREE ACCESS -
[in Japanese]1985 Volume 31 Issue 3Supplement2 Pages 707-713
Published: July 10, 1985
Released on J-STAGE: May 10, 2013
JOURNAL FREE ACCESSDownload PDF (1642K)
- |<
- <
- 1
- >
- >|